Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)
NCT02839746 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 671
Last updated 2019-11-01
Summary
Describe patient and physician assessed factors for patient well-being when treated with Pradaxa for stroke and embolism prevention in atrial fibrillation either compared to previous antithrombotic treatment (switcher)
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-13
- Primary Completion
- 2018-10-10
- Completion
- 2018-10-10
Countries
- Spain
More Related Trials
-
Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)
NCT07163338 ·Status: RECRUITING ·Phase: NA
-
Antiplatelet Therapy to Prevent Stroke in African Americans
NCT00004727 ·Status: COMPLETED ·Phase: PHASE4
-
Cilostazol for Prevention of Recurrent Stroke Trial
NCT07174414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
NCT00234065 ·Status: COMPLETED ·Phase: PHASE4
-
Antiphospholipid Antibodies & Osteopontin as Risk Factors for Cerebrovascular Stroke in Young Adults
NCT03561285 ·Status: UNKNOWN
-
Strategy for Improving Stroke Treatment Response
NCT05948566 ·Status: RECRUITING ·Phase: PHASE2
-
REstart or STop Antithrombotic Randomised Trial in France
NCT02966119 ·Status: TERMINATED ·Phase: PHASE3
-
Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.
NCT00766545 ·Status: COMPLETED ·Phase: PHASE3
-
Cilostazol Stroke Prevention Study for Antiplatelet Combination
NCT01995370 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Improvement and Safety of the Ankle Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke Patients With Decreased Ankle Brachial Arterial Pressure Index and Intermittent Claudication of Lower Limb Vascular Atherosclerosis.
NCT06424548 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke
NCT00814268 ·Status: COMPLETED ·Phase: PHASE4
-
Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients
NCT03823274 ·Status: COMPLETED
-
Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
NCT06591351 ·Status: RECRUITING ·Phase: PHASE3
-
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
NCT06591299 ·Status: RECRUITING ·Phase: PHASE3
-
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
NCT00061373 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety
NCT01142284 ·Status: COMPLETED ·Phase: PHASE2
-
Clopidogrel Versus Cilostazol in Ischemic Stroke
NCT06242132 ·Status: COMPLETED ·Phase: PHASE3
-
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
NCT01013532 ·Status: UNKNOWN ·Phase: PHASE4
-
Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)
NCT03701360 ·Status: COMPLETED
-
Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
NCT06242145 ·Status: COMPLETED ·Phase: PHASE3
-
OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial
NCT03759938 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
NCT02483169 ·Status: UNKNOWN ·Phase: PHASE4
-
Cilostazol and Aspirin in Stroke and TIA
NCT06522113 ·Status: COMPLETED ·Phase: PHASE4
-
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
NCT06243133 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Cilostazol Following Peripheral Endovascular Procedures
NCT02770274 ·Status: UNKNOWN ·Phase: PHASE3